|
|
Article: Endocardial Solutions, Inc. Reports Third Quarter Results
- Article from:
- PR Newswire
- Article date:
- October 29, 1997
CopyrightCOPYRIGHT 1997 PR Newswire Association LLC. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan. All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)
|
MINNEAPOLIS/ST. PAUL, Minn., Oct. 29 /PRNewswire/ -- Endocardial Solutions, Inc. (Nasdaq: ECSI), which is engaged in the development of diagnostic products for the electrophysiology market, today reported financial results for the third quarter ended September 30, 1997. Net loss for the third quarter was $2.183 million, or $0.25 per share, compared with a net loss of $1.422 million, or $0.23 per share for the same period in 1996.
"We achieved a number of critical milestones during the quarter, moving us closer to European introduction of our EnSite(TM) system," said Jim Bullock, President and CEO. "In August we received ISO 9001 certification for our ...
Related newspaper, magazine, and journal articles:
|
|
Article: Endocardial Solutions Announces Third Quarter ...
PR Newswire;
October 20, 1999 ;
700+ words
... ... PRNewswire/ -- Endocardial Solutions, Inc. (Nasdaq ... of 1998. The net loss for the third ... operations of Endocardial Solutions. Endocardial Solutions, Inc. Consolidated ... 721 167,738 Net loss for the period ...
|
|